Skip to content
AnalystLens

SGI · Somnigroup International

23 filings

10-K

SGI 10-K Annual Reports

Somnigroup International - 23 annual reports

Filing record · 2016–202610-K1110-Q338-K223

SGI filed 11 annual reports (10-K), 33 quarterly reports (10-Q) and 223 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Jun ’17Jun ’17
  2. Material agreement8-K · Oct ’19Oct ’19
  3. Leadership change8-K · Dec ’21Dec ’21
  4. Leadership change8-K · Sep ’25Sep ’25
  1. 2025

    Somnigroup International Annual Report, Year Ended Dec 31, 2025

    Somnigroup International Inc. reported net sales of $7,476.5 million for 2025, up 51.6% from $4,930.9 million in 2024. The increase was driven mainly by the February 5, 2025 acquisition of Mattress Firm, which contributed $3,505.4 million of sales for the stub period from February 5 through December 31, 2025. Gross margin rose to 42.6% from 41.1%, and operating income increased 19.0% to $754.9 million. Net income was essentially flat at $384.1 million, down 0.1%, while diluted EPS fell 14.8% to $1.84. Management's adjusted measures were stronger: adjusted operating income rose 41.2% to $1,018.7 million, adjusted net income rose 24.2% to $565.3 million, and adjusted EPS rose 5.9% to $2.70. The acquisition substantially increased leverage. Interest expense, net rose 98.7% to $267.9 million, and total debt increased to $4,717.3 million from $3,844.5 million. The ratio of consolidated indebtedness less netted cash to adjusted EBITDA was 3.21 times, within the 5.00 times maximum in the 2023 Credit Agreement. The company expects to return to its target leverage range of 2.0 to 3.0 times in 2026 and to allocate at least 50% of free cash flow to dividends and share repurchases. Operating cash flow was $800.1 million, and the quarterly dividend was raised to $0.17 per share. No shares were repurchased in 2025, and approximately $774.5 million remained under the authorization. The company also disclosed that it excluded Mattress Firm from its assessment of internal control over financial reporting for 2025, and that Mattress Firm represented approximately 68% of total consolidated assets and approximately 47% of consolidated net sales. Ernst & Young LLP issued an unqualified opinion on the financial statements and on internal control, with the accounting for the Mattress Firm acquisition identified as a critical audit matter.

    Feb 27, 2026
  2. 2024

    Somnigroup International Annual Report, Year Ended Dec 31, 2024

    Somnigroup International Inc. (filed under this name; the company was named Somnigroup International Inc. effective February 18, 2025, and trades on the NYSE under "SGI") reported 2024 net sales of $4,930.9 million, up 0.1% from $4,925.4 million in 2023, with North America net sales down 1.7% and International up 6.7%. Gross margin rose to 44.2% from 43.2%, operating income increased 4.4% to $634.2 million, and diluted EPS rose 3.8% to $2.16. Adjusted EPS, a non-GAAP measure, increased 6.3% to $2.55. Net cash provided by operating activities was $666.5 million, and the company bought back no shares in 2024 while its Mattress Firm acquisition was pending. The company closed the acquisition of Mattress Firm on February 5, 2025 for an aggregate purchase price of approximately $5.1 billion, consisting of $2.8 billion in cash and about 34.2 million shares. The deal was funded with new borrowings, including $625.0 million under the Delayed Draw Term A Loan, $679.5 million of revolver borrowings and about $1,592.0 million of Term B Loan proceeds released from escrow. Management said leverage was approximately 3.5 times after the closing and expects to return to its target of 2.0 to 3.0 times within twelve months. The company also expects to divest 73 Mattress Firm locations and the Sleep Outfitters subsidiary (103 locations and seven distribution centers) to Mattress Warehouse in the second quarter of 2025. Beginning in the first quarter of 2025, it will report three segments: Tempur Sealy North America, Tempur Sealy International and Mattress Firm. Key risks in the filing include the integration of Mattress Firm, a higher debt load that limits flexibility, the loss of a significant portion of OEM business after a customer's acquisition (which management expects to weigh on 2025 results), and the continuing July 2023 cybersecurity incident. The Board declared a quarterly dividend of $0.15 per share for the first quarter of 2025.

    Feb 28, 2025
  3. 2023

    Somnigroup International Annual Report, Year Ended Dec 31, 2023

    Tempur Sealy International, Inc. (now Somnigroup International) reported full-year 2023 net sales of $4,925.4 million, essentially flat versus $4,921.2 million in 2022 (up 0.1%). Gross margin rose to 43.2% from 41.6%, but operating income fell 10.8% to $607.2 million and net income attributable to the company fell 19.2% to $368.1 million, or $2.08 diluted EPS. Adjusted EPS was $2.40 versus $2.60, a 7.7% decline. Results were weighed down by $49.0 million of transaction costs tied to the pending Mattress Firm acquisition, a $14.3 million cybersecurity event, and higher interest expense of $129.9 million, up 26.1%. The pending Mattress Firm acquisition, valued at approximately $4.0 billion, is expected to be funded with about $2.7 billion of cash and 34.2 million shares, and is expected to close in the second half of 2024 subject to regulatory approvals, including an FTC second request the company said it substantially complied with. Management expects 2024 leverage of 3.0 to 3.25 times, returning to 2.0 to 3.0 times after closing. Year-end 2023 leverage was 2.87 times, total debt was $2,593.6 million, and liquidity was $1,041.3 million. Share repurchases were largely suspended ahead of the deal, and the quarterly dividend was raised to $0.13 per share. Operating cash flow from continuing operations rose to $570.3 million from $378.8 million, with capital expenditures down to $185.4 million from $306.5 million. The company also resolved the Danish Tax Matter in 2023, which contributed to a lower effective tax rate of 21.8%.

    Feb 16, 2024
  4. 2022

    Somnigroup International Annual Report, Year Ended Dec 31, 2022

    Tempur Sealy International, Inc. (the Company) reported net sales of $4.92 billion for 2022, down 0.2% from $4.93 billion in 2021, while net sales on a constant currency basis increased 1.8%. Operating income fell to $680.6 million from $912.3 million, and net income attributable to the Company declined to $455.7 million from $624.5 million. Diluted EPS was $2.53 versus $3.06 in 2021. Gross margin compressed to 41.6% from 43.8%, which management attributed to operational headwinds, expense deleverage, ERP system transition costs and the mix and acquisition effects of Dreams in the International segment. North America net sales decreased 4.7%, driven by Wholesale channel weakness tied to U.S. consumer behavior, while International net sales rose 21.5%, aided by the August 2021 Dreams acquisition. Cash flow and balance sheet changed meaningfully. Operating cash flow from continuing operations fell to $378.8 million from $723.1 million, reflecting increased inventory investment. Capital expenditures rose to $306.5 million, and the Company expects 2023 capital expenditures to decrease to approximately $200 million. Total debt increased to $2.83 billion from $2.35 billion, and the consolidated indebtedness less netted cash to adjusted EBITDA ratio was 3.10 times, within the 5.00 times covenant limit. The Company repurchased 18.6 million shares for approximately $621.2 million in 2022, leaving about $779.5 million under its authorization, and declared a quarterly dividend of $0.11 per share for the first quarter of 2023. Management highlighted a Danish tax matter, where SKAT and the IRS reached a preliminary framework in December 2022 that produced an income tax benefit in the fourth quarter, with the framework expected to be finalized during 2023. The Company also noted that consumer confidence has affected its order trends and plans new product launches in 2023, including a Stearns & Foster refresh, new Tempur-Pedic Breeze mattresses and a new Tempur line in over 90 international markets.

    Feb 17, 2023
  5. 2021

    Somnigroup International Annual Report, Year Ended Dec 31, 2021

    Tempur Sealy International, Inc. (now Somnigroup International) reported fiscal 2021 results in its Form 10-K filed February 22, 2022. Net sales rose 34.1% to $4,930.8 million from $3,676.9 million, driven by North America net sales growth of 29.1% and International net sales growth of 64.5%, which included the August 2, 2021 acquisition of Dreams. Net income increased 79.0% to $624.5 million, and diluted EPS rose 86.6% to $3.06. Adjusted EPS, a non-GAAP measure, increased 67.0% to $3.19. Gross margin declined to 43.8% from 44.6%, which the company attributed to commodity cost inflation, price increases without a margin benefit, and the lower-margin Dreams business. Management said supply chain constraints limited U.S. sales growth in 2021, though these constraints were largely resolved by year-end. Cash generation and balance sheet activity were significant. Operating cash flow from continuing operations was $723.1 million, and cash and cash equivalents ended the year at $300.7 million. The company repurchased $801.4 million of stock in 2021, leaving approximately $1,400.7 million available under its authorization, and repurchased an additional 7.7 million shares for approximately $305.0 million after year-end. Total debt increased to $2,353.2 million from $1,370.3 million, largely from the issuance of the 2029 and 2031 Senior Notes, and the ratio of consolidated indebtedness less netted cash to adjusted EBITDA was 1.81 times, within the 5.00 times covenant limit. The company expects 2022 capital expenditures of approximately $250 million to $280 million and plans to repurchase at least 10.0% of common shares outstanding in 2022, subject to market conditions. The filing also flags risks, including raw material and commodity price volatility, concentration among large customers (top five customers were approximately 33% of net sales, with one wholesale customer at approximately 15%), exposure to foreign exchange, and an unresolved Danish tax matter with a liability of approximately $50.1 million as of December 31, 2021 that is subject to an Advance Pricing Agreement process between the IRS and SKAT.

    Feb 22, 2022
  6. 2020

    Somnigroup International Annual Report, Year Ended Dec 31, 2020

    Tempur Sealy International, Inc. (now Somnigroup International) reported full-year 2020 net sales of $3,676.9 million, up 18.4% from $3,106.0 million in 2019, with net income attributable to the company of $348.8 million, up from $189.5 million. Diluted EPS rose to $1.64 from $0.86, and adjusted EPS, a non-GAAP measure, rose 91.0% to $1.91. Growth was driven by strong demand during the COVID-19 pandemic, with North America net sales up 21.3% to $3,159.2 million and International up 3.0% to $517.7 million. Operating income was $532.1 million, or 14.5% of net sales, versus $346.7 million in 2019. The balance sheet and cash generation strengthened over the year. Operating cash flow from continuing operations was $654.7 million, compared with $314.8 million in 2019. Total debt fell to $1,370.3 million from $1,547.0 million, and the consolidated indebtedness less netted cash to adjusted EBITDA per credit facility ratio was 1.68 times, against a covenant maximum of 5.00 times. Management described this as the lowest leverage in the company's history. The company repurchased $285.9 million of stock under its program in 2020, the board raised the authorization to $400.0 million in February 2021, and a first quarterly dividend of $0.07 per share was declared for payment in March 2021. The filing also flags material risks. These include COVID-19 disruption to retail traffic, a supply constraint on an encased innerspring component that limited Sealy and Sherwood production in the second half of 2020, rising commodity costs expected into 2021, and an ongoing Danish tax matter with a liability of $187.5 million at year-end. The Danish matter is also a critical audit matter for the auditor, Ernst & Young LLP, which issued an unqualified opinion.

    Feb 19, 2021
  7. 2019

    Somnigroup International Annual Report, Year Ended Dec 31, 2019

    Tempur Sealy International, Inc. reported net sales of $3.106 billion for 2019, up 14.9% from $2,702.9 million in 2018 (16.0% on a constant currency basis). Operating income rose to $346.7 million, or 11.2% of net sales, from $256.3 million, or 9.5%, and net income attributable to the company was $189.5 million versus $100.5 million. Diluted EPS was $3.42 compared with $1.82 in 2018. Adjusted EBITDA increased 19.6% to $508.1 million, and the ratio of consolidated indebtedness less netted cash to adjusted EBITDA was 2.92 times, within the 5.00 times covenant limit. Growth was driven by North America, where net sales increased 18.6% to $2.53 billion, including the Sleep Outfitters acquisition and new supply agreements with Mattress Firm, Big Lots and Beter Bed Holding. International net sales rose 1.1% to $572.7 million, or 5.3% on a constant currency basis. Operating expenses increased 14.7%, and the company expects to increase research and development spending and record advertising spending in 2020. Customer-related charges of $29.8 million tied to the Mattress PAL bankruptcy weighed on results. Looking ahead, the company expects significantly higher volume in North America in 2020, plans to open about 20 Tempur-Pedic retail stores, and completed the acquisition of an 80% interest in Sherwood Bedding in January 2020 for about $40 million. The Board raised the share repurchase authorization to $300.0 million in February 2020, and the company remains exposed to an unresolved Danish tax matter with a liability of $166.7 million including interest and penalties.

    Feb 24, 2020
  8. 2018

    Somnigroup International Annual Report, Year Ended Dec 31, 2018

    Tempur Sealy International, Inc. (filed under this name; now Somnigroup International) reported 2018 net sales of $2.70 billion, essentially flat versus $2.70 billion in 2017 (up 0.1%, or down 0.3% on a constant currency basis). Gross margin was 41.5% in both years, but operating income fell to $256.3 million from $295.5 million, and GAAP net income attributable to the company declined to $100.5 million from $151.4 million, or $1.82 per diluted share versus $2.77. Adjusted EBITDA was $424.7 million versus $445.6 million. Management attributes the 2018 pressure to the phased U.S. rollout of new Tempur products, which brought launch costs, cannibalization of higher-priced products, and a delay to ensure product quality, along with customer bankruptcies that produced $31.3 million of bad debt expense. Leverage and capital allocation were key themes. Total debt was $1,653.8 million at year-end 2018, and the ratio of consolidated funded debt less qualified cash to adjusted EBITDA was 3.87 times, within the 5.00 times covenant limit. The company made no share repurchases in 2018 and had approximately $226.9 million remaining under its authorization. It also divested certain Latin American subsidiaries, which are presented as discontinued operations, and it resolved the long-running Danish Tax Matter with SKAT and the IRS for the 2001 through 2011 settlement years, while maintaining an uncertain tax liability for later years under an advance pricing agreement program. Looking ahead, the filing expects gross margin to benefit in 2019 from Tempur sales growth, pricing actions of approximately $30 million, and improved merchandising mix, partly offset by a slight decline in Sealy sales in North America. It also flags a customer bankruptcy (Innovative Mattress Solutions, LLC) for which the company submitted a stalking horse bid of up to $26 million, and expects foreign exchange translation to reduce 2019 net sales by approximately $30 million.

    Feb 25, 2019
  9. 2017

    Somnigroup International Annual Report, Year Ended Dec 31, 2017

    Tempur Sealy International, Inc. reported 2017 net sales of $2,754.4 million, down 12.0% from $3,128.9 million in 2016, driven by the termination of its relationship with Mattress Firm, which was its largest customer in 2016 and represented 21.4% of 2016 sales. Net income attributable to the company was $151.4 million ($2.77 diluted EPS) versus $190.6 million ($3.19) in 2016. Operating income fell to $288.4 million from $410.4 million, while adjusted EBITDA was $448.5 million compared with $521.6 million. The company said that excluding Mattress Firm, North America net sales increased $176.6 million, or 9.3%, in 2017. Operating cash flow improved to $222.9 million from $165.5 million. Balance sheet and capital allocation: total debt was $1,762.5 million at year-end 2017, down from $1,901.0 million, and the company's ratio of funded debt less qualified cash to adjusted EBITDA was 3.91 times against a 5.00 times covenant limit. Management's target is 3.5 times, and it expects the ratio to be slightly above the target range in the first quarter of 2018. The company repurchased 0.6 million shares for $40.1 million in 2017 and had $226.9 million remaining under its authorization, with repurchases possibly resuming in 2018. It pays no dividend. Key risks and 2018 outlook: the filing highlights a pending Danish tax matter with SKAT, a major 2018 North America product launch that management says substantially drives 2018 performance, expected commodity cost inflation, foreign exchange headwinds, and pending securities class action and derivative litigation along with a dispute with Mattress Firm. The 2017 results also include a net income tax benefit of $23.8 million from the U.S. Tax Reform Act and charges tied to a Latin American subsidiary, which the company revised prior-period results to reflect.

    Mar 1, 2018
  10. 2016

    Somnigroup International Annual Report, Year Ended Dec 31, 2016

    Tempur Sealy International, Inc. (filed under this name; now Somnigroup International) reported fiscal 2016 net sales of $3,127.3 million, down 0.8% from $3,151.2 million in 2015 (up 0.7% on a constant currency basis). Net income attributable to the company rose to $202.1 million from $73.5 million, and diluted EPS was $3.38 versus $1.17. The 2015 result included a $60.7 million charge related to the Danish Tax Matter. Adjusted EPS, a non-GAAP measure, increased 27.0% to $4.05, and adjusted EBITDA increased 14.4% to $521.6 million. Gross margin improved to 41.9% from 39.6%, and operating income rose 34.4% to $415.5 million. The most significant forward-looking item is the termination of the company's relationship with Mattress Firm, its largest customer, which accounted for 21.4% of 2016 sales (with Sleepy's, the combined figure was 21.4% and 23.7% for 2016 and 2015). The company issued termination notices as of January 27, 2017 and expects to wind down the relationship in the first quarter of 2017. Management expects a significant negative short-term impact on financial performance, a decline in 2017 net sales versus 2016, lower U.S. market share, restructuring charges, non-cash write-offs, and possible impairment indicators for intangible assets. Leverage and capital returns were central in 2016. Total debt rose to $1,901.0 million from $1,479.6 million, driven by a new 2016 Credit Agreement and $600.0 million of 5.500% 2026 Senior Notes. The company repurchased 8.7 million shares for approximately $533.0 million, and in February 2017 the Board increased the repurchase authorization by $200 million, leaving approximately $227 million available as of February 16, 2017. The ratio of consolidated funded debt less qualified cash to EBITDA was 3.60 times, within the 5.00 times covenant. The company paid no dividends.

    Feb 24, 2017
  11. 2015

    Somnigroup International Annual Report, Year Ended Dec 31, 2015

    Tempur Sealy International, Inc. reported net sales of $3,151.2 million for 2015, up 5.4% from $2,989.8 million in 2014, with growth in both the North America and International segments on a constant currency basis. Gross margin rose to 39.6% from 38.5%, and operating income increased to $309.1 million from $276.3 million. Net income attributable to the company fell to $73.5 million from $108.9 million, largely because of a $60.7 million charge to increase the uncertain tax liability tied to the Danish tax matter with SKAT. Adjusted EPS, a non-GAAP measure, increased 20.4% to $3.19, and adjusted EBITDA increased 12.7% to $455.8 million. The company's balance sheet and liquidity show total debt of $1,479.6 million at December 31, 2015, against cash and cash equivalents of $153.9 million. The company stated that it was in compliance with its financial covenants, with a funded debt less qualified cash to EBITDA ratio of 3.21 times against a 4.50 times limit. In 2015 it issued $450.0 million of 5.625% senior notes due 2023 and used the proceeds to reduce term loan debt. The $115.2 million 8.0% Sealy Notes mature July 15, 2016. In February 2016 the board authorized a share repurchase program of up to $200 million, and the company does not pay a dividend. Customer concentration and tax exposure are the main risk factors highlighted. The top five customers accounted for approximately 39.4% of 2015 net sales, and Mattress Firm together with Sleepy's represented approximately 25% of 2015 net sales following Mattress Firm's February 5, 2016 acquisition of Sleepy's. The filing describes the SKAT assessments as potentially material and says the company expects to resume negotiations with SKAT. The company also expects to refinance its senior credit facility in the first half of 2016.

    Feb 12, 2016
  12. 2014

    Somnigroup International Annual Report, Year Ended Dec 31, 2014

    Tempur Sealy International, Inc. reported net sales of $2,989.8 million for 2014, up 21.3% from $2,464.3 million in 2013, driven mainly by a full year of Sealy results following the March 18, 2013 Sealy Acquisition and growth in each of its three segments. Net income attributable to the company was $108.9 million, or $1.75 diluted EPS, versus $78.6 million and $1.28 in 2013. Gross margin declined to 38.5% from 41.2%, reflecting the lower-margin Sealy business, while operating income rose to $276.3 million from $243.8 million. The company stated adjusted EPS of $2.65 for 2014 versus $2.38 in 2013. Leverage remains a central investor consideration. Total debt was $1,602.3 million at December 31, 2014, down from $1,836.5 million a year earlier, and stockholders' equity was $202.7 million. The company reported a funded debt less qualified cash to adjusted EBITDA ratio of 3.89 times, within the 4.75 times covenant limit, which steps down to 4.50 times from September 30, 2015 through December 31, 2015. Management expects foreign exchange to weigh more heavily on results in 2015 than in 2014, and it plans to reach over $70.0 million of cumulative cost synergies by 2016. The filing also highlights several contingent exposures, including a Danish tax assessment cumulatively totaling approximately $215.1 million including interest and penalties, a securities class action dismissed by the district court and now on appeal, an appraisal action tied to the Sealy acquisition, and a German Federal Cartel Office investigation. The company did not pay dividends in 2014 or 2013, and it had no share repurchases in the fourth quarter of 2014.

    Feb 13, 2015
  13. 2013

    Somnigroup International Annual Report, Year Ended Dec 31, 2013

    Tempur Sealy International, Inc. reported net sales of $2,464.3 million for 2013, up from $1,402.9 million in 2012, driven mainly by the March 18, 2013 acquisition of Sealy Corporation, whose post-acquisition net sales were $1,114.7 million. Net income attributable to the company was $78.6 million, compared with $106.8 million in 2012, and diluted EPS was $1.28 versus $1.70. Gross margin fell to 41.2% from 50.9%, reflecting the lower-margin Sealy business and product mix, and operating income was $243.8 million, including $44.6 million of transaction and integration costs related to the Sealy Acquisition. Interest expense, net rose to $110.8 million from $18.8 million. The balance sheet and cash flows were reshaped by the acquisition. Total debt rose to $1,836.5 million at year-end from $1,025.0 million, and total stockholders' equity was $118.6 million. Net cash provided by operating activities fell to $98.5 million from $189.9 million, while investing outflows reached $1,213.0 million. The company reported a funded debt less qualified cash to EBITDA ratio of 4.4 times, within its covenant limit of 5.25 times, and it paid no dividends in 2013 or 2012. Management noted that Tempur North America net sales declined 5.6% and operating income fell 53.2%, and it expects cost synergies in excess of $70.0 million by 2016. Key open risks include a Danish tax dispute with SKAT covering assessments of approximately $206.1 million including interest and penalties, a securities class action filed in 2012, a consumer class action filed in October 2013, and an appraisal action by former Sealy shareholders. The company also has $375.0 million of 6.875% Senior Notes and 8.0% Sealy Notes that holders may convert to cash before maturity, which could affect liquidity.

    Feb 21, 2014
  14. 2012

    Somnigroup International Annual Report, Year Ended Dec 31, 2012

    Tempur-Pedic International Inc. reported net sales of $1,402.9 million for 2012, down from $1,417.9 million in 2011, with net income falling to $106.8 million from $219.6 million and diluted EPS of $1.70 versus $3.18. The decline was driven primarily by increased competition in the North American segment, where net sales decreased to $964.3 million, while International net sales rose to $438.6 million. Gross profit margin fell to 50.9% from 52.4%, and operating income margin declined to 17.7% from 24.0%. Income tax expense rose to $122.4 million, including a $48.1 million charge tied to the repatriation of foreign earnings. The company cited adjusted EPS of $2.61 for 2012 in its non-GAAP reconciliation. The central strategic item is the pending acquisition of Sealy Corporation for approximately $1,300.0 million in total consideration, at $2.20 per share in cash, expected to close in the first half of 2013 subject to Hart-Scott-Rodino clearance. To finance it, the company entered into a $1,770.0 million credit agreement and issued $375.0 million of 6.875% Senior Notes due 2020, with the notes held in escrow pending closing. Management expects total indebtedness of about $1,900.0 million after the deal, and expects more than $40.0 million of cost synergies by the third year after closing. As of December 31, 2012, long-term debt was $1,025.0 million against stockholders' equity of $22.3 million, and the funded debt to EBITDA ratio was 2.24 times against a covenant maximum of 3.0 times. Investors should weigh the sharp earnings decline and rising competition in North America against the leverage the Sealy transaction will add. The filing also discloses a pending Danish tax dispute with a cumulative assessment of about $146.2 million including interest and penalties, and six class action lawsuits related to the Sealy merger, for which a proposed settlement in Delaware provides no additional monetary consideration.

    Feb 1, 2013
  15. 2011

    Somnigroup International Annual Report, Year Ended Dec 31, 2011

    Tempur-Pedic International Inc. (now Somnigroup International) reported strong fiscal 2011 results. Net sales rose to $1.42 billion from $1.11 billion in 2010, an increase of $312.5 million, or 28.3%. Gross profit margin improved to 52.4% from 50.2%, and operating income margin rose to 24.0% from 22.2%. Net income was $219.6 million, or $3.18 per diluted share, compared with $2.16 per diluted share in 2010. Operating cash flow was $248.7 million. The company's growth was driven mainly by its North American Retail channel, where mattress sales increased on new product launches such as the TEMPUR-Cloud collection and higher advertising investment. International net sales increased 23.9% to $413.2 million, or about 15.7% on a constant currency basis. Advertising expense rose to $148.8 million, or 10.5% of Net sales, from $96.6 million, or 8.7%. Balance sheet leverage increased during the year. Long-term debt reached $585.0 million, up from $407.0 million, while stockholders' equity fell to $30.8 million from $126.0 million after $368.5 million of share repurchases in 2011. The Senior Credit Facility was amended in June 2011 to $770.0 million in total availability, and the funded debt to EBITDA ratio was 1.50 times against a covenant maximum of 3.0 times. In January 2012 the Board approved a new share repurchase authorization of up to $250.0 million. Key risks include a Danish tax assessment totaling approximately $103.1 million including interest and penalties, and an antitrust class action that management believes is remote.

    Jan 30, 2012
  16. 2010

    Somnigroup International Annual Report, Year Ended Dec 31, 2010

    Tempur-Pedic International Inc. reported a strong 2010 in its annual report on Form 10-K. Net sales rose to $1,105.4 million from $831.2 million in 2009, an increase of $274.3 million, or 33.0%. Gross profit margin improved to 50.2% from 47.4%, and operating income reached $245.9 million, or 22.2% of net sales, compared with $144.9 million, or 17.4%, in 2009. Net income was $157.1 million, or $2.16 per diluted share, versus $85.0 million, or $1.12 per diluted share, the prior year. The company attributed the growth to the TEMPUR-Cloud collection, its "Ask Me" advertising campaign, and recovery in the U.S. mattress market, with North America Net sales up 47.0% to $772.0 million. The balance sheet and capital allocation shifted notably during the year. Total long-term debt rose to $407.0 million from $297.5 million, largely to fund $250.0 million of share repurchases (8.5 million shares). Stockholders' equity fell to $126.0 million from $172.3 million. Operating cash flow increased to $184.1 million, and capital expenditures were $18.1 million. The company reported a Funded debt to Adjusted EBITDA ratio of 1.45 times, within the 3.0 times covenant limit under its 2005 Senior Credit Facility, which matures in June 2012 and which management plans to refinance in 2011. On January 13, 2011, the Board authorized a new share repurchase program of up to $200.0 million. Key risks disclosed include a pending Danish tax assessment totaling approximately $69.3 million including interest and penalties, an antitrust class action (Jacobs) on which the company considers a loss remote, a New York Attorney General lawsuit over its unilateral retail price policy that was dismissed by the court on January 14, 2011 (subject to appeal), and sensitivity of interest expense to rates, with a 1.0% increase estimated to raise annual interest expense by $3.1 million.

    Jan 31, 2011
  17. 2009

    Somnigroup International Annual Report, Year Ended Dec 31, 2009

    Tempur-Pedic International Inc. (filed under this name; now Somnigroup International, SGI) reported net sales of $831.2 million for the year ended December 31, 2009, down from $927.8 million in 2008 and $1,106.7 million in 2007. Net income rose to $85.0 million, or $1.12 per diluted share, from $58.9 million, or $0.79, in 2008. Gross profit margin improved to 47.4% from 43.2%, and operating income margin rose to 17.4% from 14.4%. The company attributed the top-line decline primarily to a weak U.S. macroeconomic environment that reduced consumer traffic and demand, with Domestic net sales down 8.0% and International net sales down 14.4%. The balance sheet and cash generation improved meaningfully. Total debt was reduced by $121.9 million to $297.5 million at year-end, and the Funded debt to EBITDA ratio was 1.68 times against a covenant maximum of 3.0 times. Operating cash flow was $135.0 million, and capital expenditures were $14.3 million. The company suspended its dividend in late 2008 to pay down debt and did not repurchase shares in 2008 or 2009. On January 13, 2010, the Board approved a new share repurchase program of up to $100.0 million, which replaces the October 2007 authorization. Key risks include an antitrust class action (Jacobs v. Tempur-Pedic) that the company says it cannot predict the outcome of, a New York Attorney General inquiry into its unilateral retail price policy, and a pending Danish tax assessment of approximately $39.3 million including interest and penalties. The filing also discloses concentration risk, with the top five customers accounting for 18.9% of 2009 net sales, and leverage of $297.5 million in long-term debt against stockholders' equity of $172.3 million.

    Feb 8, 2010
  18. 2008

    Somnigroup International Annual Report, Year Ended Dec 31, 2008

    Tempur-Pedic International Inc. reported net sales of $927.8 million for 2008, down from $1,106.7 million in 2007, a decrease of $178.9 million, or 16.2%. Net income fell to $58.9 million from $141.5 million, and diluted earnings per share were $0.79 versus $1.74 a year earlier. The Domestic segment drove the decline, with Domestic net sales down 21.3% to $570.7 million, while International net sales fell 6.4% to $357.1 million (down about 11.4% on a constant currency basis). Gross margin compressed to 43.2% from 48.3%, reflecting raw material cost inflation and lower production volumes, and the effective tax rate rose to 45.2% from 33.6%, partly due to an $11.6 million charge tied to repatriating foreign earnings. management focused on balance sheet repair during 2008. Total debt was reduced by $182.7 million to $419.3 million, inventories fell to $60.5 million from $106.5 million, and operating cash flow rose to $198.4 million from $126.4 million. The quarterly dividend was suspended in October 2008 to redirect cash to debt reduction, and no shares were repurchased in 2008, leaving $280.1 million available under the October 2007 authorization. Stockholders' equity was $72.4 million at year-end. The company also described a $150.0 million repatriation of foreign earnings, with the first phase completed in Q4 2008 and the remainder expected in 2009. Significant uncertainties remain. The company faces an antitrust class action (Jacobs v. Tempur-Pedic), a New York Attorney General inquiry into its unilateral retail price policy, and a Danish tax assessment totaling $39.3 million including interest and penalties. Management states it cannot predict the outcome of the antitrust matter or estimate a range of loss, and expects the U.S. and European economic environment to remain challenging.

    Feb 12, 2009
  19. 2008

    Somnigroup International Annual Report, Year Ended Feb 13, 2008

    Tempur-Pedic International Inc. (now Somnigroup International, SGI) reported 2007 Net sales of $1,106.7 million, up 17.1% from $945.0 million in 2006. Operating income rose to $244.1 million, with operating income at 22.1% of Net sales in both 2007 and 2006. Net income was $141.5 million, a 12.8% net income margin, and diluted earnings per share were $1.74. Retail was the largest channel at $920.0 million of Net sales, and Domestic and International segment Net sales were $725.3 million and $381.4 million, respectively. Cash flow and capital allocation were central to the year. Net cash provided by operating activities fell to $126.4 million from $165.8 million, mainly because of higher inventory levels, which reduced operating cash flow by $59.5 million. The company repurchased 11,060,874 shares for $319.9 million, funded primarily by increased borrowings under its domestic revolving credit facility. Long-term debt rose to $601.8 million, and Stockholders' Equity was $48.1 million at December 31, 2007. The Board initiated a cash dividend in 2007, paid $23.8 million in dividends, and declared a first-quarter 2008 dividend of $0.08 per share. It also authorized an additional $300.0 million share repurchase in October 2007. The filing also flags risks for investors. Sensitivity to interest rates is material: a one-percentage-point increase would reduce income before income taxes by approximately $6.0 million. The company received a Danish tax assessment covering 2001 through 2003, which it plans to contest. Securities and antitrust class actions remain pending, and the antitrust action was dismissed in December 2007, with plaintiffs' motion to alter or amend the judgment still under briefing. President and CEO H. Thomas Bryant announced plans to retire in mid-2008.

    Feb 29, 2008
  20. 2006

    Somnigroup International Annual Report, Year Ended Dec 31, 2006

    Tempur-Pedic International Inc. (the Company, referred to in the filing as Tempur-Pedic International; now Somnigroup International) reported net sales of $945.0 million for 2006, up 13% from $836.7 million in 2005, with net income of $112.3 million, or $1.28 per diluted share, compared with $99.3 million and $0.97 in 2005. Gross margin was 49% versus 51% a year earlier, as management attributed the decline to the growth of the lower-margin Retail channel, product mix, discounted floor models and raw material costs, and it expects gross margin to be slightly down in 2007 because of the ramp-up of its New Mexico facility. Operating income rose 10% to $209.3 million, and cash flow from operations increased to $165.8 million from $102.2 million. The Company repurchased 11.3 million shares for $144.0 million in 2006 and redeemed its $97.5 million 10.25% Senior Subordinated Notes, which contributed to a $10.7 million loss on debt extinguishment. Total long-term debt was $361.1 million at year-end 2006, and stockholders' equity was $213.4 million. In January 2007 the Board authorized an additional $100.0 million share repurchase and initiated an annual cash dividend of $0.24 per share, with the first quarterly payment of $0.06 per share due March 14, 2007. The filing also discloses several pending legal matters: a securities class action filed in October and November 2005 that the Company says lacks merit, derivative complaints, and an antitrust class action filed on January 5, 2007 concerning the pricing of its mattresses. The Company states it intends to defend all of these claims vigorously and that it cannot predict the outcome of the securities action.

    Feb 28, 2007
  21. 2005

    Somnigroup International Annual Report, Year Ended Dec 31, 2005

    Tempur-Pedic International Inc. (NYSE: TPX; now Somnigroup International, SGI) reported net sales of $836.7 million for 2005, up 22% from $684.9 million in 2004, with net income of $99.3 million, or $0.97 diluted EPS, versus $75.0 million and $0.73 a year earlier. Retail channel sales rose 31% to $639.0 million and remained the largest and fastest-growing channel, while the Direct, Healthcare and Third party channels were flat or slightly down. The filing notes that sales growth slowed considerably in the second half of 2005, with fourth-quarter net sales up 9%, and that U.S. Retail sales were below expectations amid a more challenging retail environment. Gross profit margin was 51% and operating income rose 26% to $190.9 million. The balance sheet became more leveraged during 2005. Long-term debt outstanding was $344.5 million against stockholders' equity of $226.3 million, driven by a new 2005 Senior Credit Facility, $53.9 million of Series A industrial revenue bonds tied to the New Mexico plant, and $155.7 million of foreign earnings repatriated under the American Jobs Creation Act. Capital expenditures were $84.9 million, including $73.0 million for the New Mexico facility, which the company expects to complete in the fourth quarter of 2006 at an estimated cost of about $90.0 million. The board increased the share repurchase authorization to $180.0 million in January 2006, with $76.0 million spent in 2005 and a further $42.8 million through February 24, 2006. The filing also discloses a putative securities class action filed in October and November 2005 alleging misleading disclosures between April 22 and September 19, 2005, along with related derivative complaints. The company says it strongly believes the securities action lacks merit and intends to defend it vigorously. Chief Executive Officer Robert B. Trussell, Jr. is retiring at the 2006 annual meeting, and President H. Thomas Bryant will succeed him.

    Mar 14, 2006
  22. 2004

    Somnigroup International Annual Report, Year Ended Dec 31, 2004

    Tempur-Pedic International Inc. (now Somnigroup International) reported net sales of $684.9 million for 2004, up from $479.1 million in 2003, an increase of $205.8 million, or 43%. Gross profit rose to $361.0 million (53% of net sales), operating income to $151.0 million (22% of net sales), and net income to $75.0 million (11% of net sales). Diluted earnings per share were $0.73, compared with $0.39 in 2003. International sales accounted for approximately 37% of 2004 net sales. Growth was led by the Retail channel, which rose $176.1 million, or 56%, to $489.5 million, while mattresses represented 63% of sales and pillows 20%. The company's balance sheet strengthened over the year. Long-term debt fell to $289.7 million from $376.5 million, and stockholders' equity rose to $213.6 million from $122.7 million. Operating cash flow was $77.0 million and capital expenditures were $38.4 million. Management expects 2005 capital expenditures of approximately $94.0 million, including about $70.5 million for the Albuquerque, New Mexico manufacturing facility, which is expected to be completed by the second quarter of 2006 at an estimated cost of $90.0 million. The filing also notes risks including leverage, competition from larger rivals, dependence on two polyol suppliers, product liability exposure, and a 120-day return policy that generated approximately $30.7 million in U.S. returns in 2004. The company, which completed its initial public offering in December 2003 and trades on the NYSE under the symbol TPX, does not pay dividends and intends to retain earnings to fund growth. Its principal stockholders, TA Associates and Friedman Fleischer & Lowe, together owned approximately 49% of fully diluted common stock at December 31, 2004.

    Mar 8, 2005
  23. 2003

    Somnigroup International Annual Report, Year Ended Dec 31, 2003

    Tempur-Pedic International Inc. (filed as TWI Holdings, Inc. and later renamed, with ticker TPX on the NYSE) reported net sales of $479.1 million for 2003, up from a pro forma $298.0 million in 2002, an increase of $181.1 million, or 60.8%. Operating income was $97.1 million and net income was $37.6 million, with diluted earnings per share of $0.39. The company describes itself as a vertically-integrated manufacturer, marketer and distributor of premium visco-elastic foam mattresses and pillows, selling in 54 countries under the Tempur and Tempur-Pedic brands. Gross margin improved to 53.3% from 51.0% in the pro forma 2002 period, and the company credits manufacturing capacity utilization and higher-margin international sales. The filing's balance sheet and cash flow profile reflect the August 2003 recapitalization and the December 23, 2003 initial public offering. The company distributed $160.0 million to equityholders, paid $39.4 million in an earn-out to former owners of Tempur World, and issued $150.0 million of 10¼% senior subordinated notes. Long-term debt was $366.0 million at December 31, 2003, and stockholders' equity was $122.7 million. Net cash provided by operating activities was $47.0 million, and capital expenditures were $32.6 million. Net proceeds to the company from the IPO were approximately $79.0 million, of which about $57.9 million was used to redeem 35% of the senior subordinated notes in January 2004. Key risks highlighted include intense competition, rising leverage and interest rate exposure, a controlling ownership position of about 61.3% held by TA and FFL, dependence on two suppliers for polyol, and a $2.2 million annual interest impact per 1% rate increase. The company also disclosed that it was not in compliance with a capital expenditure covenant at December 31, 2003 but obtained a waiver, and that it was in compliance with all restrictive covenants as of March 1, 2004.

    Mar 30, 2004